Dental Implant Failure Rate: What the Evidence Says

Four factors shift dental implant failure odds most in the evidence: smoking, glycaemic control in diabetes, bone quality, and implant surface.

Smoking. This is one of the most consistently reported patient-level risks. A 2024 systematic review of 32 studies covering more than 59,000 implants found smokers had roughly two-and-a-half times the odds of early failure compared with non-smokers. Across all timepoints, a separate large meta-analysis put the overall increase at about 140% higher odds of failure. The effect is dose-related, and the encouraging counterpoint is that it is modifiable: reducing or stopping before treatment improves the outlook, and former smokers show lower risk than current smokers in the evidence. Because the framing here is balanced rather than disqualifying, the question of whether can smokers get dental implants has its own detailed answer.

Diabetes. The evidence is reassuring where control is good. Recent systematic reviews report survival of around 90 to 95% in diabetic patients whose blood sugar is well managed, comparable to non-diabetics, while poorly controlled diabetes, indicated by an HbA1c level above 8%, is linked to more bone loss and higher complication rates. Systemic health, in other words, is less about a diagnosis than about how well a condition is managed.

Bone quality. Denser bone integrates more reliably. A systematic review grouping implants by bone density found survival of 97.6% in the densest (Type I) bone falling to 88.8% in the softest (Type IV) bone, the low-density bone typically found at the back of the upper jaw.

Implant surface. Modern roughened surfaces outperform older machined ones, and the gap widens in difficult bone. In low-density bone, treated-surface implants showed about 97.1% survival against 91.6% for machined surfaces. Part of the lower survival seen in soft bone reflects these older machined designs, which modern roughened surfaces have improved on. This is a property of the surface class, not a ranking of specific brands, and no reliable head-to-head brand failure data supports comparing named systems.

In clinical practice, the factors that raise risk are usually visible before treatment begins, which is exactly why they can be planned around rather than discovered too late. An honest assessment includes whether the timing is right for you, not only whether treatment is possible at all.

The dental implant failure figures on this page are averages drawn from research populations, so they describe groups and trends, not guarantees for any one person.

Several caveats apply. Much of the long-term data comes from older implant systems, and surfaces have improved since, which may make current real-world results better than some pooled figures suggest. Studies also vary in how they define failure and how long they follow patients, and those with the longest follow-up necessarily use the oldest technology. It is also worth setting the numbers in context: dental implants are not routinely available on the NHS and are usually provided privately, so most published outcome data comes from private and specialist care. Absolute contraindications and drug-related risks, such as certain bone medications, sit outside the scope of this statistical page and belong in an individual clinical review. Read the numbers as a well-evidenced sense of scale, not a personal forecast.